These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23333939)

  • 1. "Non-ischemic delayed enhancement".
    Walker CM; Chung JH; Reddy GP
    J Thorac Imaging; 2013 Mar; 28(2):W27. PubMed ID: 23333939
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease.
    Moraes GL; Higgins CB; Ordovas KG
    J Thorac Imaging; 2013 Mar; 28(2):84-92; quiz 93-5. PubMed ID: 23422782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.
    Cummings KW; Bhalla S; Javidan-Nejad C; Bierhals AJ; Gutierrez FR; Woodard PK
    Radiographics; 2009; 29(1):89-103. PubMed ID: 19168838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI to assess arrhythmia and cardiomyopathies.
    Macedo R; Schmidt A; Rochitte CE; Lima JA; Bluemke DA
    J Magn Reson Imaging; 2006 Dec; 24(6):1197-206. PubMed ID: 17083108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New MR insights of cardiomyopathy.
    Rodríguez E; Soler R
    Eur J Radiol; 2008 Sep; 67(3):392-400. PubMed ID: 18455342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-ischemic causes of delayed myocardial hyperenhancement on MRI.
    Lim RP; Srichai MB; Lee VS
    AJR Am J Roentgenol; 2007 Jun; 188(6):1675-81. PubMed ID: 17515393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of imaging characteristics of magnetic resonance myocardial delayed enhancement between ischemic and nonischemic myocardial diseases].
    Lin SB; Zhang ZH; Li DJ; Zhang SY; Chen LB; Feng F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):84-7. PubMed ID: 19317068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyopathy: magnetic resonance imaging evaluation.
    Mueller GC; Attili A
    Semin Roentgenol; 2008 Jul; 43(3):204-22. PubMed ID: 18486682
    [No Abstract]   [Full Text] [Related]  

  • 11. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: diagnostic value of a typical pattern of late gadolinium enhancement.
    Thomson LE
    J Am Coll Cardiol; 2008 Mar; 51(10):1031-2. PubMed ID: 18325443
    [No Abstract]   [Full Text] [Related]  

  • 13. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
    Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
    J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of cardiomyopathy.
    Belloni E; De Cobelli F; Esposito A; Mellone R; Perseghin G; Canu T; Del Maschio A
    AJR Am J Roentgenol; 2008 Dec; 191(6):1702-10. PubMed ID: 19020239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse diseases of the myocardium: MRI-pathologic review of nondilated cardiomyopathies.
    Giesbrandt KJ; Bolan CW; Shapiro BP; Edwards WD; Mergo PJ
    AJR Am J Roentgenol; 2013 Mar; 200(3):W266-73. PubMed ID: 23436871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview.
    Kanal E
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):625-31. PubMed ID: 23088942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in magnetic resonance (2008).
    Runge VM
    Invest Radiol; 2008 Dec; 43(12):893-8. PubMed ID: 19002061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.